Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children

Completed · Phase 4

Conditions studied: Asthma

In brief

To study the improvement in airway inflammation in children with asthma non-invasively with exhaled breath NO, a marker of inflammation, after therapy with nebulized budesonide as 0.5mg daily.

Key facts

Study ID

NCT00522782

Run by

AAADRS Clinical Research Center

People needed

16

Starts

2007-08-01

Expected to finish

2009-01-01

Last updated by the study team

2009-01-23

Who can join

Age: 4 and older, up to 6. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Asthma diagnosis previously for 6 months
• Past asthma medication without change for previous 6 months
• Increased NO levels and ability to perform maneuver
• ICF signed by parents

You may not qualify if…

• Systemic steroids in past 60 days,inhaled/nebulized steroids in past 4 weeks
• Hospitalization within 3 months
• Upper or lower airways active infection or cigarette smoke direct exposure
• Use of other asthma medications other than bronchodilators one month prior and during the trial
• Noncompliance

Where it is running

• AAADRS Clinical Research Center — Coral Gables, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.